Skip to main content

Table 2 Patient characteristics

From: Presentations of tetramethylammonium hydroxide dermal exposure and the valuable potential of diphoterine solution in decontamination: a retrospective observational study

  Number of cases,
N = 29 (%)
Sex
 Male 24 (82.8%)
 Female 5 (17.2%)
Age (years)
 21–30 17 (58.6%)
 31–40 9 (31%)
 > 40 3 (10.3%)
Concentration of TMAH (%)
 25% 6 (20.7%)
 20% diluted 1 (3.4%)
 3% 1 (3.4%)
 2.38% 11 (37.9%)
 2.36% 1 (3.4%)
 1–3% 1 (3.4%)
 0.50% 2 (6.9%)
 N/A 6 (20.7%)
Exposed BSA(%)
 > 5% 2 (6.9%)
 5% 1 (3.4%)
 2% 2 (6.9%)
 2 ~ 1% 1 (3.4%)
 1% 5 (17.2%)
 < 1% 16 (55.2%)
 N/A 2 (6.9%)
Elapsed time to decontamination
 40 min 1 (3.4%)
 30 min 2 (6.9%)
 5 min 1 (3.4%)
 5 min–1 min 2 (6.9%)
 < 1 min 3 (10.3%)
 None 1 (3.4%)
 N/A 19 (65.5%)
Decontamination time
 30 min 3 (10.3%)
 20 min 3 (10.3%)
 20 min–15 min 1 (3.4%)
 15 min 2 (6.9%)
 None 1 (3.4%)
 N/A 19 (65.5%)
Diphoterine
 Used 5 (17.2%)
 None 24 (82.8%)